BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 6243416)

  • 41. Vesicular stomatitis virus growth in Drosophila melanogaster cells: G protein deficiency.
    Wyers F; Richard-Molard C; Blondel D; Dezelee S
    J Virol; 1980 Jan; 33(1):411-22. PubMed ID: 6245242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Site of synthesis of membrane and nonmembrane proteins of vesicular stomatitis virus.
    Morrison TG
    J Biol Chem; 1975 Sep; 250(17):6955-62. PubMed ID: 169263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of vesicular stomatitis virus infection by spike glycoprotein. Evidence for an intracellular, G protein-requiring step.
    Miller DK; Lenard J
    J Cell Biol; 1980 Feb; 84(2):430-7. PubMed ID: 6247355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon-mediated inhibition of virus penetration.
    Whitaker-Dowling PA; Wilcox DK; Widnell CC; Youngner JS
    Proc Natl Acad Sci U S A; 1983 Feb; 80(4):1083-6. PubMed ID: 6189119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A simple and efficient microassay method for titration of interferon.
    Ishitsuka H; Nomura Y; Takano K
    Microbiol Immunol; 1977 Oct; 21(10):583-91. PubMed ID: 201822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells.
    Borghi P; Di Marzio P; Varano B; Conti L; Belardelli F; Gessani S
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2949-54. PubMed ID: 1279103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific role of each human leukocyte type in viral infections. I. Monocyte as host cell for vesicular stomatitis virus replication in vitro.
    Edelman R; Wheelock EF
    J Virol; 1967 Dec; 1(6):1139-49. PubMed ID: 4316248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. the influence of the host cell on the inhibition of virus protein synthesis in cells double infected with vesicular stomatitis virus and mengovirus.
    Otto MJ; Lucas-Lenard J
    J Gen Virol; 1980 Oct; 50(2):293-307. PubMed ID: 6257824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Translation and identification of the viral mRNA species isolated from subcellular fractions of vesicular stomatitis virus-infected cells.
    Both GW; Moyer SA; Banerjee AK
    J Virol; 1975 Apr; 15(4):1012-9. PubMed ID: 163912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overproduction of double-stranded RNA in vesicular stomatitis virus-infected cells activates a constitutive cell-type-specific antiviral response.
    Ostertag D; Hoblitzell-Ostertag TM; Perrault J
    J Virol; 2007 Jan; 81(2):503-13. PubMed ID: 17065213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The mechanism of the antiviral effect of interferon differs in two strains of a rabbit kidney cell line.
    Whitaker-Dowling P; Kaifer C; Youngner JS
    J Interferon Res; 1987 Feb; 7(1):61-8. PubMed ID: 2438358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons.
    Ito Y; Montagnier L
    Infect Immun; 1977 Oct; 18(1):23-7. PubMed ID: 198374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of interferon action. Interferon alpha inhibits vesicular stomatitis virus primary transcript accumulation in P1/eIF-2 alpha protein kinase-deficient human fibroblast cells.
    Zhang XT; Samuel CE
    J Biol Regul Homeost Agents; 1987; 1(4):157-65. PubMed ID: 2845723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defective interfering virus particles modulate virulence.
    Cave DR; Hendrickson FM; Huang AS
    J Virol; 1985 Aug; 55(2):366-73. PubMed ID: 2991562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
    Dargan DJ; Galt CB; Subak-Sharpe JH
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Morphological and biochemical characterization of viral particles produced by the tsO45 mutant of vesicular stomatitis virus at restrictive temperature.
    Schnitzer TJ; Dickson C; Weiss RA
    J Virol; 1979 Jan; 29(1):185-95. PubMed ID: 219217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of interferon action. Inhibition of vesicular stomatitis virus in human amnion U cells by cloned human leukocyte interferon.
    Masters PS; Samuel CE
    Biochem Biophys Res Commun; 1984 Feb; 119(1):326-34. PubMed ID: 6322781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon alters intracellular transport of vesicular stomatitis virus glycoprotein.
    Singh VK; Maheshwari RK; Damewood GP; Stephensen CB; Oliver C; Friedman RM
    J Biol Regul Homeost Agents; 1988; 2(2):53-62. PubMed ID: 2461053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of vesicular stomatitis virus by kethoxal bis (thiosemicarbazone).
    Levinson W; Oppermann H; Jackson J
    J Gen Virol; 1977 Oct; 37(1):183-90. PubMed ID: 72131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of interferon on transcription and translation of vesicular stomatitis virus in human and simian cell cultures.
    Thacore HR
    J Gen Virol; 1978 Nov; 41(2):421-6. PubMed ID: 214523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.